XML 50 R32.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Value Of Financial Instruments (Tables)
12 Months Ended
Sep. 30, 2020
Fair Value of Financial Instruments  
Summary of assets and liabilities measured and recorded at fair value on Balance Sheet on a recurring basis

The following table presents assets and liabilities measured and recorded at fair value on our Consolidated Balance Sheets on a recurring basis (in thousands):

September 30, 2020

September 30, 2019

 

    

Level 1

    

Level 2

    

Level 3

    

Total

Level 1

    

Level 2

    

Level 3

    

Total

 

Assets

Current derivative assets

$

$

1,398

$

$

1,398

$

$

2,635

$

$

2,635

Noncurrent derivative assets

 

 

222

 

 

222

 

 

859

 

 

859

Total assets measured at fair value

$

$

1,620

$

$

1,620

$

$

3,494

$

$

3,494

Liabilities

Current derivative liabilities

4,557

4,557

 

529

 

529

Noncurrent derivative liabilities

 

 

14,070

 

 

14,070

 

 

228

 

 

228

Contingent consideration to seller of H4 Global

 

 

1,148

 

1,148

 

 

1,073

1,073

Contingent consideration to seller of Deltenna

 

 

 

3,004

 

3,004

 

 

 

1,787

 

1,787

Contingent consideration to seller of Shield

 

 

 

5,566

 

5,566

 

 

 

3,814

 

3,814

Contingent consideration to seller of Nuvotronics

 

 

 

 

 

4,200

4,200

Contingent consideration to seller of Delerrok

900

900

 

 

Total liabilities measured at fair value

$

$

18,627

$

10,618

$

29,245

$

$

757

$

10,874

$

11,631

Summary of change in fair value of contingent consideration liability

As of September 30, 2020, the following table summarizes the change in fair value of our Level 3 contingent consideration liabilities (in thousands):

H4 Global

  

Deltenna

  

Shield

  

Nuvotronics

  

Delerrok

  

TeraLogics

  

Total

Balance as of September 30, 2018

    

$

665

$

1,081

$

5,618

$

$

$

1,750

$

9,114

 

Initial measurement recognized at acquisition

4,900

4,900

Cash paid to seller

(385)

(1,750)

(2,135)

Adjustment to the provisional acquisition date valuation

 

 

 

 

Total remeasurement (gain) loss recognized in earnings

 

793

 

706

 

(1,804)

 

(700)

 

 

 

(1,005)

Balance as of September 30, 2019

$

1,073

$

1,787

$

3,814

$

4,200

$

$

$

10,874

Initial measurement recognized at acquisition

1,600

1,600

Cash paid to seller

Adjustment to the provisional acquisition date valuation

 

 

 

 

Total remeasurement (gain) loss recognized in earnings

 

75

 

1,217

 

1,752

 

(4,200)

 

(700)

 

 

(1,856)

Balance as of September 30, 2020

$

1,148

$

3,004

$

5,566

$

$

900

$

$

10,618